Regulated information

Vetoquinol and Klox Technologies Announce Global Animal Health Collaboration Agreement

December 12, 2019 (Lure, France) - Vetoquinol S.A. and Klox Technologies Limited, a subsidiary of Klox Technologies Inc., have entered into an exclusive global licensing agreement, excluding the People’s Republic of China.

Monthly information regarding the total number of voting rights and shares making of the share capital - November 2019

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

Monthly information regarding the total number of voting rights and shares making of the share capital - October 2019

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

Q3 2019 sales: €100.2 million (Up 11.0%)

The Vetoquinol Group posted sales of €100.2 million for the third quarter of 2019, up 11.0% as reported and up 9.4% at constant exchange rates compared to the same period last year.

Monthly information regarding the total number of voting rights and shares making of the share capital - September 2019

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

Monthly information regarding the total number of voting rights and shares making of the share capital - August 2019

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

Monthly information regarding the total number of voting rights and shares making of the share capital - July 2019

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

[AUDIO] Présentation des résultats semestriels 2019 - french

Vetoquinol - 25.07.2019 - Enregistrement Audio Conference

2019 Half year Financial Report (french)

Half year Financial Report

H1 2019 RESULTS

H1 2019 results